FI884924L - Humanimmuglobulin som producerats med hybrid-dna-teknik. - Google Patents

Humanimmuglobulin som producerats med hybrid-dna-teknik. Download PDF

Info

Publication number: FI884924L
Authority: FI; Finland
Prior art keywords: producerats; immuglobulin; som; technik; med
Prior art date: 1987-10-28

Application number

FI884924A

Other languages

English (en)

Other versions

FI884924A0 (fi

FI884924A7 (fi

Inventor

Linda J Harris

Leah A Lipsich

Michael A Walls

Original Assignee

Oncogen

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1987-10-28

Filing date

1988-10-25

Publication date

1989-04-29

1988-10-25 Application filed by Oncogen filed Critical Oncogen

1988-10-25 Publication of FI884924A0 publication Critical patent/FI884924A0/fi

1989-04-29 Publication of FI884924A7 publication Critical patent/FI884924A7/fi

1989-04-29 Publication of FI884924L publication Critical patent/FI884924L/fi

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Immunology (AREA)
Oncology (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Communicable Diseases (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

FI884924A 1987-10-28 1988-10-25 Humanimmuglobulin som producerats med hybrid-dna-teknik. FI884924L (fi)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US11463287A	1987-10-28	1987-10-28
US25400488A	1988-09-16	1988-09-16

Publications (3)

Publication Number	Publication Date
FI884924A0 FI884924A0 (fi)	1988-10-25
FI884924A7 FI884924A7 (fi)	1989-04-29
FI884924L true FI884924L (fi)	1989-04-29

Family

ID=26812406

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FI884924A FI884924L (fi)	1987-10-28	1988-10-25	Humanimmuglobulin som producerats med hybrid-dna-teknik.

Country Status (10)

Country	Link
EP (1)	EP0314161A1 (fi)
JP (1)	JPH02138989A (fi)
AU (2)	AU634151B2 (fi)
DK (1)	DK597288A (fi)
FI (1)	FI884924L (fi)
IL (1)	IL88175A0 (fi)
MY (1)	MY104344A (fi)
NO (1)	NO884795L (fi)
NZ (1)	NZ226694A (fi)
PT (1)	PT88874B (fi)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS63267295A (ja) *	1986-12-03	1988-11-04	Sumitomo Chem Co Ltd	ヒト抗体、抗体遺伝子及び対応する組換え体
US5610034A (en) *	1987-04-29	1997-03-11	Alko Group Ltd.	Immunoglobulin production by trichoderma
CA2066720A1 (en) *	1989-09-19	1991-03-20	David M. Knight	Method for improving human monoclonal antibody production
CA2045150A1 (en) *	1989-11-07	1991-05-08	Walt W. Shuford	Oligomeric immunoglobulins
EP0539395A1 (en) *	1990-07-16	1993-05-05	Alko Group Ltd.	IMMUNOGLOBULIN PRODUCTION BY $i(TRICHODERMA)
GB9022545D0 (en)	1990-10-17	1990-11-28	Wellcome Found	Culture medium
IL102490A0 (en) *	1991-07-15	1993-01-14	Wellcome Found	Production of antibodies
CA2078539C (en)	1991-09-18	2005-08-02	Kenya Shitara	Process for producing humanized chimera antibody
US5939532A (en) *	1993-09-07	1999-08-17	Kyowa Hakko Kogyo Co., Ltd	Humanized antibodies to ganglioside GM2
AU669379B2 (en) *	1992-09-07	1996-06-06	Kyowa Hakko Kirin Co., Ltd.	Humanized antibodies
US6042828A (en)	1992-09-07	2000-03-28	Kyowa Hakko Kogyo Co., Ltd.	Humanized antibodies to ganglioside GM2
US6130364A (en) *	1995-03-29	2000-10-10	Abgenix, Inc.	Production of antibodies using Cre-mediated site-specific recombination
EP1310554B1 (en)	2000-08-11	2010-05-26	Kyowa Hakko Kirin Co., Ltd.	Polypeptides controlling phosphoric acid metabolism, calcium metabolism, calcification and vitamin d metabolism and dnas encoding the same
CN101508734A (zh)	2001-04-27	2009-08-19	协和发酵麒麟株式会社	抗cd40单克隆抗体
ES2331414T3 (es)	2001-12-28	2010-01-04	Kyowa Hakko Kirin Co Ltd	Anticuerpos contra el factor 23 de crecimiento de fibroblastos.
USRE47770E1 (en)	2002-07-18	2019-12-17	Merus N.V.	Recombinant production of mixtures of antibodies
ES2442615T5 (es)	2002-07-18	2023-03-16	Merus Nv	Producción recombinante de mezclas de anticuerpos
EP1639009B1 (en)	2003-05-30	2013-02-27	Merus B.V.	Fab library for the preparation of a mixture of antibodies
US20100069614A1 (en)	2008-06-27	2010-03-18	Merus B.V.	Antibody producing non-human mammals
DK1707627T3 (da)	2003-12-25	2012-12-17	Kyowa Hakko Kirin Co Ltd	Antagonistisk anti-CD40-antistofmutant.
NZ548828A (en)	2004-01-20	2009-07-31	Merus B V	Mixtures of binding proteins
KR100918746B1 (ko)	2004-09-06	2009-09-24	교와 핫꼬 기린 가부시키가이샤	항 ａ３３ 항체
WO2007108559A1 (ja)	2006-03-23	2007-09-27	Kirin Pharma Kabushiki Kaisha	ヒトトロンボポエチン受容体に対するアゴニスト抗体
TWI390034B (zh)	2006-04-06	2013-03-21	Kyowa Hakko Kirin Co Ltd	Novel anti-CD98 antibody
GB0700133D0 (en)	2007-01-04	2007-02-14	Humabs Llc	Human cytomegalovirus neutralising antibodies and use thereof
US7947274B2 (en)	2007-01-04	2011-05-24	Humabs, LLC.	Human cytomegalovirus neutralising antibodies and use thereof
US7883705B2 (en)	2007-02-14	2011-02-08	Kyowa Hakko Kirin Co., Ltd.	Anti FGF23 antibody and a pharmaceutical composition comprising the same
US8603480B2 (en)	2008-07-16	2013-12-10	Institute For Research In Biomedicine	Human cytomegalovirus neutralizing antibodies and use thereof
ES2740749T3 (es)	2012-04-20	2020-02-06	Merus Nv	Métodos y medios para la producción de moléculas heterodiméricas similares a Ig
AU2013285355A1 (en)	2012-07-06	2015-01-29	Genmab B.V.	Dimeric protein with triple mutations
EP2711426B1 (en)	2012-09-24	2015-04-08	Lonza Biologics plc	Expression vectors comprising chimeric cytomegalovirus promoter and enhancer sequences
US10358492B2 (en)	2012-09-27	2019-07-23	Merus N.V.	Bispecific IgG antibodies as T cell engagers
SG11201607109QA (en)	2014-02-28	2016-09-29	Merus Nv	Antibodies that bind egfr and erbb3
LT3110849T (lt)	2014-02-28	2020-12-10	Merus N.V.	Antikūnai, surišantys erbb-2 ir erbb-3
AU2016293942B2 (en)	2015-07-10	2022-06-16	Merus N.V.	Human CD3 binding antibody
MA45517B1 (fr)	2015-10-23	2021-04-30	Merus Nv	Molécules de liaison inhibant la croissance de cancer
MX2019011660A (es)	2017-03-31	2019-11-18	Merus Nv	Anticuerpos biespecificos que se unen al receptor 2 del factor de crecimiento humano (erbb-2) y receptor 3 del factor de crecimiento humano (erbb3) para usarse en el tratamiento de celulas que tienen un gen de fusion de neuregulina-1 (nrg1).
BR112019024230A2 (pt)	2017-05-17	2020-06-09	Merus N.V.	combinação de um anticorpo bispecífico erbb-2 / erbb-3 com terapia endócrina para câncer de mama
AU2018312816B2 (en)	2017-08-09	2021-05-27	Merus N.V.	Antibodies that bind EGFR and cMET
JP7230819B2 (ja)	2017-10-06	2023-03-01	小野薬品工業株式会社	二重特異性抗体
TWI804572B (zh)	2018-02-09	2023-06-11	日商小野藥品工業股份有限公司	雙特異性抗體
TWI862565B (zh)	2019-04-04	2024-11-21	日商小野藥品工業股份有限公司	雙特異性抗體
TWI889320B (zh)	2019-07-05	2025-07-01	日商小野藥品工業股份有限公司	以pd-1/cd3雙特異性蛋白質所進行之血液性癌症治療
CA3149309A1 (en)	2019-07-30	2021-02-04	Ono Pharmaceutical Co., Ltd.	Bispecific antibody
TW202120550A (zh)	2019-08-08	2021-06-01	日商小野藥品工業股份有限公司	雙特異性蛋白質
AU2023329533A1 (en)	2022-08-23	2025-03-27	Ono Pharmaceutical Co., Ltd.	Bispecific antibody

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4816567A (en) *	1983-04-08	1989-03-28	Genentech, Inc.	Recombinant immunoglobin preparations
EP0247091B1 (en) *	1985-11-01	1993-09-29	Xoma Corporation	Modular assembly of antibody genes, antibodies prepared thereby and use

1988
- 1988-10-25 FI FI884924A patent/FI884924L/fi not_active IP Right Cessation
- 1988-10-25 NZ NZ226694A patent/NZ226694A/en unknown
- 1988-10-26 AU AU24363/88A patent/AU634151B2/en not_active Ceased
- 1988-10-26 IL IL88175A patent/IL88175A0/xx unknown
- 1988-10-27 MY MYPI88001221A patent/MY104344A/en unknown
- 1988-10-27 JP JP63271910A patent/JPH02138989A/ja active Pending
- 1988-10-27 PT PT88874A patent/PT88874B/pt active IP Right Grant
- 1988-10-27 DK DK597288A patent/DK597288A/da not_active Application Discontinuation
- 1988-10-27 NO NO88884795A patent/NO884795L/no unknown
- 1988-10-28 EP EP88117998A patent/EP0314161A1/en not_active Ceased
1992
- 1992-10-01 AU AU26082/92A patent/AU2608292A/en not_active Abandoned

Also Published As

Publication number	Publication date
PT88874B (pt)	1994-01-31
PT88874A (pt)	1989-07-31
AU634151B2 (en)	1993-02-18
NZ226694A (en)	1994-04-27
DK597288D0 (da)	1988-10-27
EP0314161A1 (en)	1989-05-03
JPH02138989A (ja)	1990-05-28
FI884924A0 (fi)	1988-10-25
NO884795L (no)	1989-04-28
FI884924A7 (fi)	1989-04-29
NO884795D0 (no)	1988-10-27
AU2436388A (en)	1989-06-01
DK597288A (da)	1989-04-29
IL88175A0 (en)	1989-06-30
AU2608292A (en)	1992-12-17
MY104344A (en)	1994-03-31

Publication	Publication Date	Title
FI884924L (fi)	1989-04-29	Humanimmuglobulin som producerats med hybrid-dna-teknik.
FI872756L (fi)	1987-12-24	Med laserstraolning fungerande terapeutisk anordning.
FI884063A0 (fi)	1988-09-02	Hydrokrackningskatalysatorer och -foerfaranden som anvaender icke-zeolitiska molekylsaoll.
FI884533L (fi)	1989-04-03	Underlag foer jordfri odling med kontrollerad vattenhalt i tjockleksriktningen.
FI874375A0 (fi)	1987-10-06	Flerskedesfoeraongare med en foeraongande kondensator som vaetskefoeraongningsskede.
FI902042A0 (fi)	1990-04-23	Bencement som innehaoller celltillvaextstimulans.
FI874571L (fi)	1988-08-18	Roterande koppling med balancerade taetningar.
FI884681A0 (fi)	1988-10-11	Polyamidbasfoereningar som gjorts eldfasta.
FI874722L (fi)	1988-08-01	Trycksaenkningsanordning med reglerbart utloppstryck.
FI885079L (fi)	1989-05-05	Speciellt med klorhexadin kompatibel kiseloxid foer anvaendning i tandkraemskompositioner.
FI884869L (fi)	1988-10-21	I samband med blodprovtagning anvaendbart plaoster.
FI884720L (fi)	1989-04-16	Kompositioner foer anvaendning som kontrastmedel.
FI874917L (fi)	1989-02-08	Fibermaterial som selektivt absorberar solvaerme.
FI873971L (fi)	1989-03-15	Klargoerare med filtrerande baedd.
FI881561A7 (fi)	1988-10-08	Cellulosabaserade livsmedelshoeljen som innehaoller foernaetade aeggvitefoereningar.
FI893189L (fi)	1989-06-29	Tetrahaloftalatestrar som brandskyddsvaetskor foer vissa hartser.
FI874723A0 (fi)	1987-10-27	Tryckminskningsventil med reglerbart utloppstryck.
FI873320L (fi)	1988-02-01	Telekommunikationscentralutrustning med flerpartsledningar som anvaender isdn-teknik.
DE3860318D1 (de)	1990-08-23	Gewebe-schlitzgeraet.
FI884926L (fi)	1989-04-27	Kopolymerbestrykningskompositioner som innehaoller sulfoalkylmonomeremulsionsmedel.
FI880513A0 (fi)	1988-02-04	Anordning foer foeljande med en patients livsfunktioner.
FI871028A0 (fi)	1987-03-09	Slirskydd med kombinationsstomme foer fordonsdaeck.
FI871743A0 (fi)	1987-04-21	Vaendbaedd foer en patient.
FI874396L (fi)	1989-04-08	Skyddsarrangemang foer objekt som skall skyddas.
FI874286A0 (fi)	1987-09-30	Baksladd som uppvisar en vridbar bettskiva.

Legal Events

Date	Code	Title	Description
1995-04-30	FD	Application lapsed
2004-08-31	MM	Patent lapsed	Owner name: ONCOGEN